New data suggests that two doses of the Pfizer COVID-19 vaccine do not provide very much protection from infection for children 5 to 15 years against the Omicron variant of the CCP virus, according to new data published in the Center for Disease Control and Prevention (CDC) journal, Morbidity and Mortality Weekly Report. The CDC analyzed data from the Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT) study that involved 1,3645 children ages 5 to 15 from Arizona, Texas, Florida, and Utah. Weekly nasal swabs and surveys were submitted from July 2021 through February 2022 whether the children had symptoms or not. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” Laura Olsho, principal investigator of the PROTECT project, said in a news release. “With increased use of home rapid testing, studies like ours are needed to provide more comprehensive …